Gaudensia Mutua

1.8k total citations
29 papers, 853 citations indexed

About

Gaudensia Mutua is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Gaudensia Mutua has authored 29 papers receiving a total of 853 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 14 papers in Virology and 12 papers in Epidemiology. Recurrent topics in Gaudensia Mutua's work include HIV/AIDS Research and Interventions (18 papers), HIV Research and Treatment (14 papers) and HIV, Drug Use, Sexual Risk (8 papers). Gaudensia Mutua is often cited by papers focused on HIV/AIDS Research and Interventions (18 papers), HIV Research and Treatment (14 papers) and HIV, Drug Use, Sexual Risk (8 papers). Gaudensia Mutua collaborates with scholars based in Kenya, United States and United Kingdom. Gaudensia Mutua's co-authors include Frances Priddy, Jessica E. Haberer, Peter Mugo, Eduard J. Sanders, Omu Anzala, Elisabeth M. van der Elst, Don Operario, Sagri Singh, Judie Mbogua and Caroline Y. Kuo and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and BMC Public Health.

In The Last Decade

Gaudensia Mutua

27 papers receiving 835 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gaudensia Mutua Kenya 13 743 528 265 211 206 29 853
Yuhua Ruan China 18 670 0.9× 559 1.1× 187 0.7× 319 1.5× 142 0.7× 66 881
Blayne Cutler United States 14 580 0.8× 454 0.9× 203 0.8× 129 0.6× 239 1.2× 22 754
Víctoria Hernando Spain 19 1.1k 1.4× 804 1.5× 278 1.0× 379 1.8× 342 1.7× 55 1.5k
Hong‐Ha M. Truong United States 17 760 1.0× 531 1.0× 250 0.9× 276 1.3× 281 1.4× 60 929
Patrick Ndase United States 11 973 1.3× 506 1.0× 174 0.7× 382 1.8× 311 1.5× 18 1.1k
Celine Costello Daly United States 6 597 0.8× 389 0.7× 182 0.7× 211 1.0× 349 1.7× 6 1.1k
Doug Taylor United States 13 752 1.0× 427 0.8× 144 0.5× 282 1.3× 416 2.0× 20 1.1k
Nyaradzo Mgodi United States 17 706 1.0× 425 0.8× 140 0.5× 173 0.8× 418 2.0× 61 993
Evelyn Foust United States 15 778 1.0× 505 1.0× 172 0.6× 283 1.3× 428 2.1× 25 1.0k
Ioannis Hodges-Mameletzis Switzerland 13 1.4k 1.8× 928 1.8× 515 1.9× 245 1.2× 437 2.1× 20 1.5k

Countries citing papers authored by Gaudensia Mutua

Since Specialization
Citations

This map shows the geographic impact of Gaudensia Mutua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaudensia Mutua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaudensia Mutua more than expected).

Fields of papers citing papers by Gaudensia Mutua

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaudensia Mutua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaudensia Mutua. The network helps show where Gaudensia Mutua may publish in the future.

Co-authorship network of co-authors of Gaudensia Mutua

This figure shows the co-authorship network connecting the top 25 collaborators of Gaudensia Mutua. A scholar is included among the top collaborators of Gaudensia Mutua based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaudensia Mutua. Gaudensia Mutua is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mayanja, Yunia, Wasima Rida, Joshua Kimani, et al.. (2023). Hepatitis B status and associated factors among participants screened for simulated HIV vaccine efficacy trials in Kenya and Uganda. PLoS ONE. 18(7). e0288604–e0288604.
2.
Otieno, Fredrick, Joshua Kimani, Elizabeth Wahome, et al.. (2022). Quantifying rates of HIV-1 flow between risk groups and geographic locations in Kenya: A country-wide phylogenetic study. Virus Evolution. 8(1). veac016–veac016. 8 indexed citations
3.
Mutisya, Elizabeth Mueni, Andrew Abaasa, Gaudensia Mutua, et al.. (2022). Feasibility of conducting HIV prevention trials among key populations in Nairobi, Kenya. BMC Public Health. 22(1). 2385–2385. 1 indexed citations
4.
Mutisya, Elizabeth Mueni, Gaudensia Mutua, Gloria Omosa-Manyonyi, et al.. (2020). Willingness to participate in future HIV vaccine trials among men who have sex with men and female sex workers living in Nairobi, Kenya. PLoS ONE. 15(8). e0238028–e0238028. 9 indexed citations
5.
6.
Mutua, Gaudensia, Omu Anzala, Kerstin Lühn, et al.. (2019). Safety and Immunogenicity of a 2-Dose Heterologous Vaccine Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Nairobi, Kenya. The Journal of Infectious Diseases. 220(1). 57–67. 59 indexed citations
7.
8.
Abaasa, Andrew, Craig W. Hendrix, Monica Gandhi, et al.. (2017). Utility of Different Adherence Measures for PrEP: Patterns and Incremental Value. AIDS and Behavior. 22(4). 1165–1173. 49 indexed citations
9.
Mutua, Gaudensia, et al.. (2017). Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya. PLoS ONE. 12(9). e0183788–e0183788. 15 indexed citations
10.
Anzala, Omu, Gaudensia Mutua, Carl Robinson, et al.. (2016). First data in African subjects for the monovalent Janssen Ebola Zaire heterologous prime-boost vaccines, combining Ad26.ZEBOV and MVA-BN-Filo. International Journal of Infectious Diseases. 53. 29–30. 1 indexed citations
11.
12.
Mutua, Gaudensia, Juliet Mpendo, William Kilembe, et al.. (2014). Major Negative Social Impacts Are Rare in Phase 1 HIV Vaccine Trials in Africa. AIDS Research and Human Retroviruses. 30(S1). A190–A191. 2 indexed citations
13.
Omosa-Manyonyi, Gloria, Gaudensia Mutua, Bashir Farah, et al.. (2014). Acceptability and Feasibility of Repeated Mucosal Specimen Collection in Clinical Trial Participants in Kenya. PLoS ONE. 9(10). e110228–e110228. 4 indexed citations
14.
Baxi, Sanjiv M., Albert Liu, Peter Bacchetti, et al.. (2014). Comparing the Novel Method of Assessing PrEP Adherence/Exposure Using Hair Samples to Other Pharmacologic and Traditional Measures. JAIDS Journal of Acquired Immune Deficiency Syndromes. 68(1). 13–20. 71 indexed citations
15.
Mugo, Peter, Eduard J. Sanders, Gaudensia Mutua, et al.. (2014). Understanding Adherence to Daily and Intermittent Regimens of Oral HIV Pre-exposure Prophylaxis Among Men Who Have Sex with Men in Kenya. AIDS and Behavior. 19(5). 794–801. 38 indexed citations
16.
Bezemer, Daniela, Nuno R. Faria, Amin S. Hassan, et al.. (2013). HIV Type 1 Transmission Networks Among Men Having Sex with Men and Heterosexuals in Kenya. AIDS Research and Human Retroviruses. 30(2). 118–126. 32 indexed citations
17.
Price, Matt A., Wasima Rida, Mary Mwangome, et al.. (2012). Identifying At-Risk Populations in Kenya and South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 59(2). 185–193. 99 indexed citations
18.
Mutua, Gaudensia, Eduard J. Sanders, Peter Mugo, et al.. (2012). Safety and Adherence to Intermittent Pre-Exposure Prophylaxis (PrEP) for HIV-1 in African Men Who Have Sex with Men and Female Sex Workers. PLoS ONE. 7(4). e33103–e33103. 133 indexed citations
19.
Elst, Elisabeth M. van der, Judie Mbogua, Don Operario, et al.. (2012). High Acceptability of HIV Pre-exposure Prophylaxis but Challenges in Adherence and Use: Qualitative Insights from a Phase I Trial of Intermittent and Daily PrEP in At-Risk Populations in Kenya. AIDS and Behavior. 17(6). 2162–2172. 228 indexed citations
20.
Excler, Jean‐Louis, Wasima Rida, Frances Priddy, et al.. (2010). AIDS Vaccines and Preexposure Prophylaxis: Is Synergy Possible?. AIDS Research and Human Retroviruses. 27(6). 669–680. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuhua Ruan Breakdown of academic impact, for papers by Blayne Cutler Breakdown of academic impact, for papers by Víctoria Hernando Breakdown of academic impact, for papers by Hong‐Ha M. Truong Breakdown of academic impact, for papers by Patrick Ndase Breakdown of academic impact, for papers by Celine Costello Daly Breakdown of academic impact, for papers by Doug Taylor Breakdown of academic impact, for papers by Nyaradzo Mgodi Breakdown of academic impact, for papers by Evelyn Foust Breakdown of academic impact, for papers by Ioannis Hodges-Mameletzis
Rankless by CCL
2026